Making Science Group Statistics
Total Valuation
BME:MAKS has a market cap or net worth of EUR 48.89 million. The enterprise value is 73.88 million.
| Market Cap | 48.89M |
| Enterprise Value | 73.88M |
Important Dates
The next estimated earnings date is Thursday, March 25, 2027.
| Earnings Date | Mar 25, 2027 |
| Ex-Dividend Date | Apr 28, 2026 |
Share Statistics
BME:MAKS has 8.97 million shares outstanding. The number of shares has decreased by -0.58% in one year.
| Current Share Class | 8.97M |
| Shares Outstanding | 8.97M |
| Shares Change (YoY) | -0.58% |
| Shares Change (QoQ) | +4.74% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.27% |
| Float | 4.21M |
Valuation Ratios
The trailing PE ratio is 2.04.
| PE Ratio | 2.04 |
| Forward PE | n/a |
| PS Ratio | 0.13 |
| PB Ratio | 1.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 1.96 |
| P/OCF Ratio | 1.93 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 3.11 |
| EV / Sales | 0.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2.96 |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.95.
| Current Ratio | 0.86 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.95 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.57 |
| Interest Coverage | -0.05 |
Financial Efficiency
Return on equity (ROE) is -21.17% and return on invested capital (ROIC) is -0.31%.
| Return on Equity (ROE) | -21.17% |
| Return on Assets (ROA) | -0.06% |
| Return on Invested Capital (ROIC) | -0.31% |
| Return on Capital Employed (ROCE) | -0.35% |
| Weighted Average Cost of Capital (WACC) | 8.31% |
| Revenue Per Employee | 442,593 |
| Profits Per Employee | 28,600 |
| Employee Count | 830 |
| Asset Turnover | 2.04 |
| Inventory Turnover | 97.14 |
Taxes
In the past 12 months, BME:MAKS has paid 945,476 in taxes.
| Income Tax | 945,476 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.50% in the last 52 weeks. The beta is 0.92, so BME:MAKS's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -35.50% |
| 50-Day Moving Average | 5.97 |
| 200-Day Moving Average | 7.08 |
| Relative Strength Index (RSI) | 31.34 |
| Average Volume (20 Days) | 1,581 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:MAKS had revenue of EUR 367.35 million and earned 23.74 million in profits. Earnings per share was 2.67.
| Revenue | 367.35M |
| Gross Profit | 24.10M |
| Operating Income | -186,187 |
| Pretax Income | -6.79M |
| Net Income | 23.74M |
| EBITDA | -2.83M |
| EBIT | -186,187 |
| Earnings Per Share (EPS) | 2.67 |
Balance Sheet
The company has 20.34 million in cash and 39.00 million in debt, with a net cash position of -18.66 million or -2.08 per share.
| Cash & Cash Equivalents | 20.34M |
| Total Debt | 39.00M |
| Net Cash | -18.66M |
| Net Cash Per Share | -2.08 |
| Equity (Book Value) | 41.06M |
| Book Value Per Share | 3.87 |
| Working Capital | -19.17M |
Cash Flow
In the last 12 months, operating cash flow was 25.39 million and capital expenditures -465,526, giving a free cash flow of 24.92 million.
| Operating Cash Flow | 25.39M |
| Capital Expenditures | -465,526 |
| Depreciation & Amortization | -2.64M |
| Net Borrowing | -3.06M |
| Free Cash Flow | 24.92M |
| FCF Per Share | 2.78 |
Margins
Gross margin is 6.56%, with operating and profit margins of -0.05% and 6.46%.
| Gross Margin | 6.56% |
| Operating Margin | -0.05% |
| Pretax Margin | -1.85% |
| Profit Margin | 6.46% |
| EBITDA Margin | -0.77% |
| EBIT Margin | -0.05% |
| FCF Margin | 6.78% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 4.08%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 4.08% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.43% |
| FCF Payout Ratio | 8.00% |
| Buyback Yield | 0.58% |
| Shareholder Yield | 4.65% |
| Earnings Yield | 49.02% |
| FCF Yield | 50.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:MAKS has an Altman Z-Score of 2.13 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.13 |
| Piotroski F-Score | 6 |